ProfileGDS4132 / 204521_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 30% 28% 43% 31% 32% 30% 31% 37% 28% 33% 34% 35% 37% 43% 45% 42% 51% 49% 36% 36% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10174.575430
GSM201543Muscle PCOS pioglitazone 12160.124428
GSM201544Muscle PCOS pioglitazone 161112.86343
GSM201545Muscle PCOS pioglitazone 20184.188431
GSM201829Muscle PCOS pioglitazone 23185.01632
GSM201830Muscle PCOS pioglitazon 25175.118330
GSM201831Muscle PCOS pioglitazone 27175.00231
GSM201832Muscle PCOS pioglitazone 3194.984437
GSM201833Muscle PCOS pioglitazone 4165.373628
GSM201834Muscle PCOS pioglitazone 8180.883733
GSM201835Muscle PCOS after pioglitazone 10272.622734
GSM201836Muscle PCOS after pioglitazone 12279.167435
GSM201837Muscle PCOS after pioglitazone 16278.502137
GSM201838Muscle PCOS after pioglitazone 202100.53843
GSM201839Muscle PCOS after pioglitazone 232109.88445
GSM201840Muscle PCOS after pioglitazone 252104.23642
GSM201841Muscle PCOS after pioglitazone 272122.52851
GSM201842Muscle PCOS after pioglitazone 32107.63949
GSM201843Muscle PCOS after pioglitazone 4290.017436
GSM201844Muscle PCOS after pioglitazone 8285.41936